Segment Information - Schedule of Segment Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net Revenue	$ 591,643	$ 509,728	$ 484,329
Cost of revenue	347,039	321,832	297,269
GROSS PROFIT	244,604	187,896	187,060
Clinical Services
Segment Reporting Information [Line Items]
Net Revenue	495,636	418,754	404,172
Cost of revenue	287,059	261,742	244,360
GROSS PROFIT	208,577	157,012	159,812
Amortization of acquired intangible assets	17,300	17,100
Advanced Diagnostics
Segment Reporting Information [Line Items]
Net Revenue	96,007	90,974	80,157
Cost of revenue	59,980	60,090	52,909
GROSS PROFIT	36,027	30,884	$ 27,248
Amortization of acquired intangible assets	$ 2,400	$ 2,400